October 29, 2024 Webinar: New Findings on Inequities in Rare Diseases: How They Impact Research and Clinical Trials Processes Join us Tuesday, October 29, at noon Eastern for an important webinar, New Findings on Inequities in Rare Diseases...
October 23, 2024-October 27, 2024 American Society of Nephrology (ASN) Kidney Week 2024 BmDR Oversight Committee members Nicholas King, Katrina Peron, and Gary Friedman will be attending ASN Kidney Week 2024 in....
October 16, 2024 Sanford Health Rare Disease Data Registry and C-Path’s RDCA-DAP Enter into a Master Data Contribution Agreement to Aggregate Rare Disease Data Critical Path Institute (C-Path) is pleased to announce the expansion of our partnership with the Coordination...
October 16, 2024 ADHD Awareness Month: Addressing Disparities in Diagnosis and Treatment October is ADHD Awareness Month, dedicated to raising awareness about Attention Deficit Hyperactivity Disorder (ADHD) and
October 8, 2024 Flexible approaches to eCOA administration in clinical trials: The site perspective Estelle Haenel, Celeste A. Elash, Katie Garner, Megan Turner, Scottie KernAbstract Electronic Clinical Outcome Assessment (eCOA) C
October 2, 2024 From Words to Action: Ensuring True Accessibility at Scientific Conferences I want to talk about access and inclusion at scientific conferences and putting actions to words or values. Conferences are...
October 1, 2024-October 2, 2024 Join C-Path at the Health Research Alliance Fall Conference C-Path's Maaike Everts, PhD, Executive Director of its Translational Therapeutics Accelerate (TRxA), is participating in...
October 1, 2024 The AMR Accelerator Calls to Action: European Capacity for Antibiotic R&D Requires Long-term Funding Note: You are reading this information because Critical Path Institute is a partner of both ERA4TB and Unite4TB.
September 30, 2024 C-Path to Lead Comprehensive Task Force Focused on Accelerating Drug Development for Limb-Girdle Muscular Dystrophies C-Path announced the formation of a new task for under its RDCA-DAP, dedicated to...
September 30, 2024 TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction...